Learn More
Promega RiboMAX™ Large Scale RNA Production Systems
Designed for large-scale RNA production, the RiboMAX Systems consistently produce 2-5mg RNA from a 1ml reaction volume.
$576.00
Specifications
| Content And Storage | -30°C to -10°C |
|---|---|
| For Use With (Application) | Produce 2 to 5mg/mL of RNA in a 1mL reaction, about 10- to 20-fold more RNA than is produced with the standard Riboprobe™ system transcription reaction |
| Includes | Linear control DNA, RQ1 RNase-free DNase, Nuclease-free Water, Enzyme mix, rATP, rCTP, rGTP, rUTP, Sodium Acetate, 3m (pH 5.2), 5X Transcription Buffer |
| Quantity | 1 System |
Includes: Linear control DNA; RQ1 RNase-free DNase; Nuclease-free water; Enzyme mix; rATP; rCTP; rGTP; rUTP; Sodium acetate, 3.0M (pH 5.2); Transcription buffer, 5X
| Catalog Number | Mfr. No. | Product Type | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Product Type | Price | Quantity & Availability | |||||
|
PR-P1280
|
Promega
P1280 |
RiboMAX Large Scale RNA Production System—SP6 |
Each for $576.00
|
|
PR-P1300
|
Promega
P1300 |
RiboMAX Large Scale RNA Production System—T7 |
Each for $576.00
|
|
Description
- Capped or Uncapped RNA Transcripts for in vitro or in vivo Translation
- Produces 2-5mg/mL RNA in a 1mL reaction
- Available for use with SP6 or T7 RNA polymerase
- Scalable to meet varying RNA production requirements
U.S. Patent 5,552,302; Australian Patent 646803 and other patents.
The RiboMAX Large Scale RNA Production System—T7 (Mfr. No. P1300) is covered by U.S. Patents 5,256,555; 6,586,218; 6,586,219 and other pending patents and is sold under a license from Ambion, Inc. It is intended for research use only. Parties wishing to use this product for other applications should contact Ambion, Inc.
The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673. A license (from Promega for research reagent products and from The Regents of the University of California for all other fields) is needed for any commercial sale of nucleic acid contained within or derived from this product.
Australian Patents 616881 and 641261 and other pending and issued patents, which claim vectors encoding a portion of human placental ribonuclease inhibitor, are exclusively licensed to Promega Corporation.
Specifications
| -30°C to -10°C | |
| Produce 2 to 5mg/mL of RNA in a 1mL reaction, about 10- to 20-fold more RNA than is produced with the standard Riboprobe™ system transcription reaction | |
| Linear control DNA, RQ1 RNase-free DNase, Nuclease-free Water, Enzyme mix, rATP, rCTP, rGTP, rUTP, Sodium Acetate, 3m (pH 5.2), 5X Transcription Buffer | |
| 1 System |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.